Dundee Corporation Acquires Further Interest in Diagnos Inc.
February 08 2013 - 3:42PM
Marketwired
In accordance with regulatory requirements, Dundee Corporation
(TSX:DC.A) ("Dundee") announces that it has acquired 6,000,000
units ("Units") of Diagnos Inc. ("Diagnos") in a private placement
at a price of $0.10 per Unit. Each Unit consists of one common
share in the capital of Diagnos and one common share purchase
warrant ("Warrant"). Each Warrant entitles the holder to purchase
one common share at the price of $0.15 for a period of 18
months.
Dundee now owns a position in Diagnos representing an
approximate 14.98% interest or 22.96% assuming the exercise of all
Warrants.
The position in Diagnos was acquired for investment purposes and
may be increased or decreased in the future as considered
appropriate in light of investment criteria, market conditions and
other factors and in accordance with the provisions of applicable
securities legislation.
Contacts: Dundee Corporation Ned Goodman President and Chief
Executive Officer (416) 365-5665 Dundee Corporation Lucie Presot
Vice President and Chief Financial Officer (416) 365-5157
Dundee (TSX:DC.A)
Historical Stock Chart
From Sep 2024 to Oct 2024
Dundee (TSX:DC.A)
Historical Stock Chart
From Oct 2023 to Oct 2024